Laura E. Strong, Ph.D., is President and Chief Operating Officer of Quintessence Biosciences. In this position, Dr. Strong is responsible for developing and executing the product development plan and overseeing the development of the human clinical trial plans for the Company’s drug products. Further Dr. Strong is responsible for developing relationships with current and future customers and collaborators.
Dr. Strong is serves on the boards of a variety of small private companies. She is a mentor in and co-chair of the screening committee for Madison Entrepreneurs Resource Learning and Innovation Network (MERLIN) mentors, which matches experienced and new entrepreneurs. Dr. Strong played an active role in bringing the National Small Business Innovation Research (SBIR) conference to Wisconsin in 2011 and served as co-chair for the event.
As a National Institutes of Health predoctoral fellow, Dr. Strong earned a Ph.D. in organic chemistry at the University of Wisconsin–Madison. Dr. Strong is co-author of fourteen publications and co-inventor on four patents.
Despite lots of headlines, an underappreciated storyline this year was the undercurrent surrounding the validity of medical tests:
[Updated 1/23/14, 2:23 pm.] Social media hasn’t yet changed the world for biotech and pharma companies, but I believe this year is the year that will change.
For better or worse,... Read more »
June 12, 2018
© 2007-2018, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.